Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis
We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, an...
Saved in:
Published in | The American journal of tropical medicine and hygiene Vol. 110; no. 6; pp. 1210 - 1213 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Institute of Tropical Medicine
05.06.2024
American Society of Tropical Medicine and Hygiene The American Society of Tropical Medicine and Hygiene |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (
P =
0.023) and 14.4% in subjects with neurological complaints without NCC (
P =
0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (
P
<0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection. |
---|---|
AbstractList | We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection. We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population ( P = 0.023) and 14.4% in subjects with neurological complaints without NCC ( P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients ( P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection. We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection. |
Author | Sanchez Boluarte, Arantxa N. Castillo, Yesenia Abravanel, Florence Bustos, Javier A. Dalton, Harry R. Izopet, Jacques Madden, Richie G. Abanto, Jesus Gonzales, Isidro Garcia, Hector H. Saavedra, Herbert Perez, Erika |
Author_xml | – sequence: 1 givenname: Jesus surname: Abanto fullname: Abanto, Jesus organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú;, Department of Neurology, University of Cincinnati, Cincinnati, Ohio – sequence: 2 givenname: Arantxa N. surname: Sanchez Boluarte fullname: Sanchez Boluarte, Arantxa N. organization: Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú;, Department of Global Health, University of Washington, Seattle, Washington – sequence: 3 givenname: Yesenia surname: Castillo fullname: Castillo, Yesenia organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú – sequence: 4 givenname: Erika surname: Perez fullname: Perez, Erika organization: Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú – sequence: 5 givenname: Herbert surname: Saavedra fullname: Saavedra, Herbert organization: Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú – sequence: 6 givenname: Isidro surname: Gonzales fullname: Gonzales, Isidro organization: Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú – sequence: 7 givenname: Javier A. surname: Bustos fullname: Bustos, Javier A. organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú;, Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú – sequence: 8 givenname: Florence surname: Abravanel fullname: Abravanel, Florence organization: Laboratoire de Virologie, CHU Purpan, Toulouse, France – sequence: 9 givenname: Jacques surname: Izopet fullname: Izopet, Jacques organization: Laboratoire de Virologie, CHU Purpan, Toulouse, France – sequence: 10 givenname: Richie G. surname: Madden fullname: Madden, Richie G. organization: Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, South Australia;, HEV International Direct Action Group (HEViDrAG) – sequence: 11 givenname: Hector H. surname: Garcia fullname: Garcia, Hector H. organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú;, Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú – sequence: 12 givenname: Harry R. surname: Dalton fullname: Dalton, Harry R. organization: Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, South Australia;, HEV International Direct Action Group (HEViDrAG) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38653231$$D View this record in MEDLINE/PubMed https://hal.science/hal-05038015$$DView record in HAL |
BookMark | eNpdkk1vEzEQhi1URNPCkSuyxIUetnjWnzmhqCpNpQh6AC4cLK9jE0cbO9jeoP57dkmpoKeRZp55ZzTznqGTmKJD6DWQS9aK-XuzrbvNZUsborh4hmbApGhAMH6CZoSQtpkLKk_RWSlbQkC1AC_QKVWC05bCDH2_jTY7U9wa32V3ML2L1uHk8SLW0KV1cAXXhJdub2qooeBr_C3koeAQ8d2YcrEW_CvUDf7khpzsfanBumxTCeUleu5NX9yrh3iOvn68_nK1bFafb26vFqvGMiJqQ5nwjK1NS7g0gqi19Mw7o0ApIyXvaMe5JEKClyC4VN5yTrwFzzvDLDX0HH046u6HbufWdtwpm17vc9iZfK-TCfr_Sgwb_SMdNABwRhgbFS6OCpsnfcvFSk85wglVBPgBRvbdw7Scfg6uVL0Lxbq-N9GloWhKGAeYS5hk3z5Bt2nIcbzFSMlWUUrnE_Xm3_Uf5_990gg0R8DmVEp2_hEBoicT6D8m0C3Vkwnob5ZmpG8 |
ContentType | Journal Article |
Copyright | Copyright Institute of Tropical Medicine Jun 2024 Distributed under a Creative Commons Attribution 4.0 International License 2024, American Society of Tropical Medicine and Hygiene 2024 |
Copyright_xml | – notice: Copyright Institute of Tropical Medicine Jun 2024 – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: 2024, American Society of Tropical Medicine and Hygiene 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC 5PM |
DOI | 10.4269/ajtmh.23-0856 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-1645 |
EndPage | 1213 |
ExternalDocumentID | PMC11154044 oai_HAL_hal_05038015v1 38653231 10_4269_ajtmh_23_0856 |
Genre | Journal Article |
GeographicLocations | Peru |
GeographicLocations_xml | – name: Peru |
GrantInformation_xml | – fundername: FIC NIH HHS grantid: D43 TW001140 |
GroupedDBID | --- 23M 2WC 34G 36B 53G 5GY 5RE 5VS 6J9 AAYXX ABCQX ABPPZ ACGFO ADBBV ADTPD AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION DIK E3Z EBD EBS EJD EMB EMOBN F5P GX1 H13 HYE K-O KQ8 L7B MV1 OK1 P2P PQQKQ RHI RPM SV3 TR2 TST UPT W8F WH7 WOQ WOW ~KM CGR CUY CVF ECM EIF NPM 7X8 1XC 5PM |
ID | FETCH-LOGICAL-c406t-346f44da2057a608d7f4fea8188a775b3b5570671f716578fc550fc1f5ba4c3a3 |
ISSN | 0002-9637 1476-1645 |
IngestDate | Thu Aug 21 18:36:38 EDT 2025 Fri May 09 12:24:02 EDT 2025 Fri Jul 11 13:04:10 EDT 2025 Sun Jun 29 16:37:55 EDT 2025 Mon Jul 21 06:06:14 EDT 2025 Tue Jul 01 03:04:24 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c406t-346f44da2057a608d7f4fea8188a775b3b5570671f716578fc550fc1f5ba4c3a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 PMCID: PMC11154044 Disclosure: The authors certify that they have no affiliations with or involvement in any entity with any financial interest. Authors’ addresses: Jesus Abanto, Department of Neurology, University of Cincinnati, Cincinnati, OH, and Center for Global Health, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mail: abantojs@ucmail.uc.edu. Arantxa N. Sanchez Boluarte, Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru, and Department of Global Health, University of Washington, Seattle, WA, E-mail: aransb21@uw.edu. Yesenia Castillo, Center for Global Health, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mail: yesenia.castillo.b@upch.pe. Erika Perez, Isidro Gonzales, and Herbert Saavedra, Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru, E-mails: erika.perez.p@upch.pe, isidrogonzalesq@hotmail.com, and hsaavedrapastor@hotmail.com. Javier A. Bustos and Hector H. Garcia, Center for Global Health, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru, and Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru, E-mails: jbustos@jhsph.edu and hgarcia@jhsph.edu. Florence Abravanel and Jacques Izopet, Laboratoire de Virologie, CHU Purpan, Toulouse, France, E-mails: abravanel.f@chu-toulouse.fr and izopet.j@chu-toulouse.fr. Richie G. Madden and Harry R. Dalton, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, Australia, and HEV International Direct Action Group, E-mails: richie@forfey.com and hardalton@gmail.com. Financial support: Beijing Wantai Biological donated the ELISA kits for detection of IgG and IgM antibodies against HEV used in this study. J. Abanto is partially supported by FIC NIH training grant TW001140. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11154044 |
PMID | 38653231 |
PQID | 3072833394 |
PQPubID | 105381 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11154044 hal_primary_oai_HAL_hal_05038015v1 proquest_miscellaneous_3045119714 proquest_journals_3072833394 pubmed_primary_38653231 crossref_primary_10_4269_ajtmh_23_0856 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-Jun-05 |
PublicationDateYYYYMMDD | 2024-06-05 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-Jun-05 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Deerfield, Illinois |
PublicationTitle | The American journal of tropical medicine and hygiene |
PublicationTitleAlternate | Am J Trop Med Hyg |
PublicationYear | 2024 |
Publisher | Institute of Tropical Medicine American Society of Tropical Medicine and Hygiene The American Society of Tropical Medicine and Hygiene |
Publisher_xml | – name: Institute of Tropical Medicine – name: American Society of Tropical Medicine and Hygiene – name: The American Society of Tropical Medicine and Hygiene |
References | Garcia (b16) 2016; 374 Pischke (b8) 2019; 11 Passos-Castilho (b18) 2017; 21 Mclean (b10) 2017; 17 Chandnani (b21) 2016; 17 Sarda (b22) 2009; 129 Garcia (b15) 2014; 14 (b4) 2023 Rivero-Juarez (b9) 2019; 10 Izopet (b3) 2019; 120 Vildosola (b17) 2000; 20 Garcia (b14) 2014; 55 (b5) 2021 Thom (b6) 2018; 23 Fierro (b12) 2016; 22 Van der Poel (b7) 2018; 65 Garcia (b13) 2016; 62 Wallace (b20) 2017; 29 Campolmi (b19) 2018; 98 Guerra (b1) 2017; 5 Kamar (b2) 2017; 3 Garcia (b11) 2014; 13 |
References_xml | – year: 2023 ident: b4 – volume: 20 start-page: 111 year: 2000 ident: b17 article-title: Hepatitis E IgG antibodies seroprevalence in a Peruvian risk group – volume: 17 start-page: 584 year: 2016 ident: b21 article-title: A case report about the most common yet most forgotten hepatitis E – volume: 21 start-page: 535 year: 2017 ident: b18 article-title: High prevalence of hepatitis E virus antibodies in Sao Paulo, southeastern Brazil: Analysis of a group of blood donors representative of the general population – volume: 120 start-page: 20 year: 2019 ident: b3 article-title: Hepatitis E virus infections in Europe – volume: 129 start-page: 64 year: 2009 ident: b22 article-title: Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity – volume: 3 start-page: 17086 year: 2017 ident: b2 article-title: Hepatitis E virus infection – volume: 374 start-page: 2335 year: 2016 ident: b16 article-title: Elimination of Taenia solium transmission in northern Peru – volume: 98 start-page: 1275 year: 2018 ident: b19 article-title: Seroprevalence of hepatitis A virus, hepatitis E virus, and Helicobacter pylori in rural communities of the Bolivian Chaco, 2013 – volume: 5 start-page: 376 year: 2017 ident: b1 article-title: Hepatitis E: A literature review – volume: 11 start-page: 186 year: 2019 ident: b8 article-title: Chronic Hepatitis E in rheumatology and internal medicine patients: A retrospective multicenter European cohort study – volume: 14 start-page: 687 year: 2014 ident: b15 article-title: Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: A double-blind, randomised controlled trial – year: 2021 ident: b5 – volume: 17 start-page: 282 year: 2017 ident: b10 article-title: Hepatitis E virus and neurological disorders – volume: 13 start-page: 1202 year: 2014 ident: b11 article-title: Clinical symptoms, diagnosis, and treatment of neurocysticercosis – volume: 29 start-page: 215 year: 2017 ident: b20 article-title: Investigation of liver dysfunction: Who should we test for hepatitis E? – volume: 22 start-page: 2271 year: 2016 ident: b12 article-title: Hepatitis E virus: An ancient hidden enemy in Latin America – volume: 23 start-page: 17-00174 year: 2018 ident: b6 article-title: Hepatitis E virus (HEV) in Scotland: Evidence of recent increase in viral circulation in humans – volume: 10 start-page: 1425 year: 2019 ident: b9 article-title: Hepatitis E infection in HIV-infected patients – volume: 55 start-page: 1452 year: 2014 ident: b14 article-title: Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after – volume: 65 start-page: 22 year: 2018 ident: b7 article-title: Knowledge gaps and research priorities in the prevention and control of hepatitis E virus infection – volume: 62 start-page: 1375 year: 2016 ident: b13 article-title: Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis |
SSID | ssj0018211 |
Score | 2.4315522 |
Snippet | We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological... |
SourceID | pubmedcentral hal proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1210 |
SubjectTerms | Adolescent Adult Aged Antibodies Female Hepatitis Hepatitis Antibodies Hepatitis Antibodies - blood Hepatitis E Hepatitis E - epidemiology Hepatitis E - immunology Hepatitis E virus Hepatitis E virus - immunology Humans Immunoglobulin G Immunoglobulin G - blood Life Sciences Male Middle Aged Neurocysticercosis Neurocysticercosis - complications Neurocysticercosis - epidemiology Neurocysticercosis - immunology Neurological disorders Patients Peru Peru - epidemiology Prevalence Seroepidemiologic Studies Short Report Young Adult |
Title | Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38653231 https://www.proquest.com/docview/3072833394 https://www.proquest.com/docview/3045119714 https://hal.science/hal-05038015 https://pubmed.ncbi.nlm.nih.gov/PMC11154044 |
Volume | 110 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwFLY6g4S4IHYKAzIIcalSmthZehygqCwzQqKDBnGIbNcmAZGM2hQx87v4gbznpFnaHgYuUZQ4m9_zW_I-fybkGROuVIGJnADchcOVNs5YSOmM5p7yhRKesez6R8fB9IS_O_VPe70_LdTSqpBDdbFzXsn_SBWOgVxxluw_SLa-KRyAfZAvbEHCsL2UjGFwI6ZcI94fabvtKMXQMitSmSM-EEPLqUbUdJEuB5PB53SxsgjYjyWfajW5zVJ0qHO7sNdC5ct02Q5aZ83sk6xNNVEs8jMr43WB3lYikvNvcOdGkyQuU1wCaZarOoL_BNqW6IvBS-gghJVaGwV-s_gtBsfDpjICr1RVh77gPKlUNLZ8Uf78Bkv-Q7R_Xnjcgqz8DYMMNqD0ubq0wTwMHMji_I6RrsCv6ZbJRQa0lvtGirpdrgGn7KLf-178TIYecyDU3EHBveEaa8AipEp4g9heHnssxsv3yBUPkhNcN-P12_d17SryXHeddOGnlcyuePmLztM7kdBegjjc7SRnE6vbCn5mN8j1Kmuhh6UK3iQ9nd0iV48qsd8mX2tNpI0m0tzQRhNpkdNaE-mEWk2kaUbXmkhRE-m2Jt4hJ28ms1dTp1q2w1EQHRYO44HhfC48SAVEMIrmoeFGC4gMIxGGvmQSad-C0DWQq4PDMAqyZKNc40vBFRPsLtnP8kzfJxRMh5TjyPeN4ly7euxKMUYKzZEODWNhnzxfd2F8VrKzxDtF1SdPoYPrNsipPj38EOMxS4gEQfEvt08O1v0fV4NpGYMPhAicsTHvkyf1abDBWFgTmc5X2IbbcrwLbe6V4qofhWvqMkii-iTqCLLzLt0zWZpYnncXqbJGnD-47Fc-JNeaQXZA9ovFSj-CmLmQj62K_gVu4MdT |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Prevalence+of+Antibodies+to+Hepatitis+E+Virus+in+Patients+with+Neurocysticercosis&rft.jtitle=The+American+journal+of+tropical+medicine+and+hygiene&rft.au=Abanto%2C+Jesus&rft.au=Sanchez+Boluarte%2C+Arantxa+N.&rft.au=Castillo%2C+Yesenia&rft.au=Perez%2C+Erika&rft.date=2024-06-05&rft.issn=0002-9637&rft.eissn=1476-1645&rft.volume=110&rft.issue=6&rft.spage=1210&rft.epage=1213&rft_id=info:doi/10.4269%2Fajtmh.23-0856&rft.externalDBID=n%2Fa&rft.externalDocID=10_4269_ajtmh_23_0856 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9637&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9637&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9637&client=summon |